Growth Metrics

Immunocore Holdings (IMCR) Depreciation Expense (2020 - 2021)

Immunocore Holdings' Depreciation Expense history spans 2 years, with the latest figure at $519725.9 for Q3 2021.

  • On a quarterly basis, Depreciation Expense fell 41.12% to $519725.9 in Q3 2021 year-over-year; TTM through Sep 2021 was $2.4 million, a N/A change, with the full-year FY2020 number at $856972.7, changed N/A from a year prior.
  • Depreciation Expense hit $519725.9 in Q3 2021 for Immunocore Holdings, down from $525545.8 in the prior quarter.
  • Over the last five years, Depreciation Expense for IMCR hit a ceiling of $882703.9 in Q3 2020 and a floor of $478485.5 in Q1 2021.